PCM
APYX icon

Prelude Capital Management’s Apyx Medical APYX Stock Holding History

Prelude Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,134
Closed -$27K – 1418
2019
Q4 		$27K Buy
+3,134
New +$22.6K ﹤0.01% 1520
2017
Q2 		– Sell
-2,989
Closed -$8K – 1587
2017
Q1 		$8K Sell
2,989
-5,100
-63% -$16.9K ﹤0.01% 1376
2016
Q4 		$29K Buy
+8,089
New +$36K ﹤0.01% 1236

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prelude Capital Management's APYX Position: Q1 2020 in Review

Prelude Capital Management sold out of Apyx Medical (APYX) in Q1 2020, closing a stake of 3,134 shares — an estimated $27K sold.

Prelude Capital Management first reported a position in APYX in Q4 2016 and held it in 3 quarters. The position peaked at $29K in Q4 2016. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2020.

  • Prelude Capital Management reported no remaining Apyx Medical position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 3,134 Apyx Medical shares in Q1 2020, an estimated $27K.
  • Prelude Capital Management first reported a position in Apyx Medical in Q4 2016 and held it in 3 quarters.
  • Prelude Capital Management's Apyx Medical position peaked at $29K in Q4 2016.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.